Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent

Cancer Letters

Volumn 221, Issue 2, 2005, Pages 153-163

  Reiners Jr , John J ^a   Kessel, David ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2; Cell cycle; HA14 1; U937

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; CASPASE 3; DNA; PROTEIN BCL 2; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER SUSCEPTIBILITY; CELL CYCLE G1 PHASE; CELL CYCLE PHASE; CELL CYCLE S PHASE; CELL KILLING; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA CONTENT; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOSIS INHIBITION; MYELOMONOCYTIC LEUKEMIA; PRIORITY JOURNAL;

EID: 16244375885     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.012     Document Type: Article

References (34)

1. J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326
2. W.-X. Zong, T. Lindsten, A.J. Ross, G.R. MacGregor, and C.B. Thompson BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak Genes Dev. 15 2001 1481 1486
3. M.C. Wei, W.-X. Zong, E.H. Cheng, T. Lindsten, V. Panoutsakopoulou, and A.J. Ross Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death Science 292 2001 727 730
4. 2+ stores J. Biol. Chem. 277 2002 9216 9225
5. 2+ mobilization promotes cytochrome c release during apoptosis J. Biol. Chem. 277 2002 20301 20308
6. M.J. Thomenius, N.S. Wang, E.Z. Reineks, Z. Wang, and C.W. Distelhorst Bcl-2 on the endoplasmic reticulum regulates Bax activity by binding to BH3-only proteins J. Biol. Chem. 278 2003 6243 6250
7. L differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24 Oncogene 22 2003 8758 8773
8. L can differentially block chemotherapy-induced cell death Blood 90 2000 1208 1216
9. 2+ homeostasis and apoptosis Eur. Mol. Biol. Org. J. 23 2004 1207 1216
10. Y. Dai, M. Rahmani, S.J. Corey, P. Dent, and S. Grant A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2 J. Biol. Chem. 279 2004 34227 34239
11. P. Juin, O. Geneste, E. Raimbaud, and J.A. Hickman Shooting at survivors: Bcl-2 family members as drug targets for cancer Biochim. Biophys. Acta 1644 2004 251 260
12. J.L. Wang, Z.J. Zhang, S. Choksi, S. Shan, Z. Lu, and C.M. Croce Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells Cancer Res. 60 2000 1498 1502
13. J.L. Wang, D. Liu, Z.J. Zhang, S. Shan, X. Han, and S.M. Srinivasula Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells Proc. Natl Acad. Sci. USA 97 2000 7124 7129
14. J. An, Y. Chen, and Z. Huang Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor J. Biol. Chem. 279 2004 19133 19140
15. J.H. Hao, M. Yu, F.T. Liu, A.C. Newland, and L. Jia Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells Cancer Res. 64 2004 3607 3616
16. D. Kessel, M. Castelli, and J.J. Reiners Jr. Apoptotic response to photodynamic therapy versus the Bcl-2 antagonist HA14-1 Photochem. Photobiol. 76 2002 314 319
17. 1 phase-dependent expression of Bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells Mol. Pharmacol. 58 2000 1001 1010
18. S. Haldar, N. Jena, and C.M. Croce Inactivation of Bcl-2 by phosphorylation Proc. Natl Acad. Sci. USA 92 1995 4507 4511
19. S. Wang, Z. Wang, L. Boise, P. Dent, and S. Grant Loss of the Bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis Biochem. Biophys. Res. Commun. 259 1999 67 72
20. 2/M Mol. Cell. Biol. 19 1999 8469 8478
21. X.Y. Pei, Y. Dai, and S. Grant The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells Leukemia 17 2003 2036 2045
22. J.D. Lickiliter, N.J. Wood, L. Johnson, G. McHugh, J. Tan, and F. Wood HA14-1 selectively induces apoptosis in Bcl-2 overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death Leukemia 17 2003 2074 2080
23. H. Yamaguchi, S.R. Paranawithana, M.W. Lee, Z. Huang, K.N. Bhalla, and H-G. Wang Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells Cancer Res. 62 2002 466 471
24. J. Chen, A. Freeman, J. Liu, Q. Dai, and R.M. Lee The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195 Mol. Cancer Ther. 1 2002 961 967
25. M. Milella, Z. Estrov, S.M. Kornblau, B.Z. Carter, M. Konopleva, and A. Tari Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia Blood 99 2002 3461 3464
26. M. Milella, S.M. Kornblau, Z. Estrov, B.Z. Carter, H. Lapillonne, and D. Harris Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia J. Clin. Invest. 108 2001 851 859
27. C.E. Denlinger, M.D. Keller, M.W. Mayo, R.M. Broad, and D.R. Jones Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer J. Thorac. Cardiovasc. Surg. 127 2004 1078 1086
28. R.P. Santini, S. Myrand, C. Elferink, and J.J. Reiners Jr. Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase J. Pharmacol. Exp. Ther. 299 2001 718 728
29. J.J. Reiners Jr., R. Clift, and P. Mathieu Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor Carcinogenesis 20 1999 1561 1566
30. J.J. Reiners Jr., J.A. Caruso, P. Mathieu, B. Chelladurai, X-M. Yin, and D. Kessel Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage Cell Death Differ. 9 2002 934 944
31. D.G. Tang, L. Li, D.P. Chopra, and A.T. Porter Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins Cancer Res. 58 1998 3466 3479
32. B.Z. Carter, M. Milella, D.C. Albert, and M. Andreeff Cytokine-regulated expression of survivin in myeloid leukemia Blood 97 2001 2784 2790
33. E. Beltrami, J. Plescia, J.C. Wilkinson, C.S. Duckett, and D.C. Altieri Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis J. Biol. Chem. 279 2004 2077 2084
34. 2/M phase arrest and apoptosis in human non-small cell lung cancer cell lines Clin. Cancer Res. 9 2003 1145 1154